175 related articles for article (PubMed ID: 20353301)
1. Contribution of oxygen-limiting conditions to persistent infection of Pseudomonas aeruginosa.
Schobert M; Tielen P
Future Microbiol; 2010 Apr; 5(4):603-21. PubMed ID: 20353301
[TBL] [Abstract][Full Text] [Related]
2. Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung.
Schobert M; Jahn D
Int J Med Microbiol; 2010 Dec; 300(8):549-56. PubMed ID: 20951638
[TBL] [Abstract][Full Text] [Related]
3. A natural antisense transcript regulates mucD gene expression and biofilm biosynthesis in Pseudomonas aeruginosa.
Yang Z; Jin X; Rao X; Hu F
Mikrobiologiia; 2011; 80(6):756-62. PubMed ID: 22393760
[TBL] [Abstract][Full Text] [Related]
4. Alginate production by the mucoid Pseudomonas aeruginosa associated with cystic fibrosis.
Gill JF; Deretic V; Chakrabarty AM
Microbiol Sci; 1987 Oct; 4(10):296-9. PubMed ID: 3155272
[TBL] [Abstract][Full Text] [Related]
5. Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomonas aeruginosa.
Williams HD; Zlosnik JE; Ryall B
Adv Microb Physiol; 2007; 52():1-71. PubMed ID: 17027370
[TBL] [Abstract][Full Text] [Related]
6. A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence.
Balasubramanian D; Schneper L; Kumari H; Mathee K
Nucleic Acids Res; 2013 Jan; 41(1):1-20. PubMed ID: 23143271
[TBL] [Abstract][Full Text] [Related]
7. Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts.
Rau MH; Hansen SK; Johansen HK; Thomsen LE; Workman CT; Nielsen KF; Jelsbak L; Høiby N; Yang L; Molin S
Environ Microbiol; 2010 Jun; 12(6):1643-58. PubMed ID: 20406284
[TBL] [Abstract][Full Text] [Related]
8. Effect of pH on production of virulence factors by biofilm cells of Pseudomonas aeruginosa.
Harjai K; Khandwahaa RK; Mittal R; Yadav V; Gupta V; Sharma S
Folia Microbiol (Praha); 2005; 50(2):99-102. PubMed ID: 16110911
[TBL] [Abstract][Full Text] [Related]
9. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets.
Hassett DJ; Cuppoletti J; Trapnell B; Lymar SV; Rowe JJ; Yoon SS; Hilliard GM; Parvatiyar K; Kamani MC; Wozniak DJ; Hwang SH; McDermott TR; Ochsner UA
Adv Drug Deliv Rev; 2002 Dec; 54(11):1425-43. PubMed ID: 12458153
[TBL] [Abstract][Full Text] [Related]
10. [Alginate, elastase and alkaline protease production of Pseudomonas aeruginosa strains isolated from various body sites].
Ciragil P; Söyletir G
Mikrobiyol Bul; 2004 Oct; 38(4):341-7. PubMed ID: 15700659
[TBL] [Abstract][Full Text] [Related]
11. Impact of alginate-producing Pseudomonas aeruginosa on alveolar macrophage apoptotic cell clearance.
McCaslin CA; Petrusca DN; Poirier C; Serban KA; Anderson GG; Petrache I
J Cyst Fibros; 2015 Jan; 14(1):70-77. PubMed ID: 25027418
[TBL] [Abstract][Full Text] [Related]
12. Panax ginseng has anti-infective activity against opportunistic pathogen Pseudomonas aeruginosa by inhibiting quorum sensing, a bacterial communication process critical for establishing infection.
Song Z; Kong KF; Wu H; Maricic N; Ramalingam B; Priestap H; Schneper L; Quirke JM; Høiby N; Mathee K
Phytomedicine; 2010 Nov; 17(13):1040-6. PubMed ID: 20554187
[TBL] [Abstract][Full Text] [Related]
13. Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients.
Lee B; Schjerling CK; Kirkby N; Hoffmann N; Borup R; Molin S; Høiby N; Ciofu O
APMIS; 2011 Apr; 119(4-5):263-74. PubMed ID: 21492226
[TBL] [Abstract][Full Text] [Related]
14. Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis.
Ramsey DM; Wozniak DJ
Mol Microbiol; 2005 Apr; 56(2):309-22. PubMed ID: 15813726
[TBL] [Abstract][Full Text] [Related]
15. Pseudomonas aeruginosa biofilms in cystic fibrosis.
Høiby N; Ciofu O; Bjarnsholt T
Future Microbiol; 2010 Nov; 5(11):1663-74. PubMed ID: 21133688
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic and environmental mutagenesis drive diversification and persistence of Pseudomonas aeruginosa in chronic lung infections.
Rodríguez-Rojas A; Oliver A; Blázquez J
J Infect Dis; 2012 Jan; 205(1):121-7. PubMed ID: 22080096
[TBL] [Abstract][Full Text] [Related]
17. Effects of ambroxol on alginate of mature Pseudomonas aeruginosa biofilms.
Li F; Yu J; Yang H; Wan Z; Bai D
Curr Microbiol; 2008 Jul; 57(1):1-7. PubMed ID: 18389310
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
[TBL] [Abstract][Full Text] [Related]
19. Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates.
Tramper-Stranders GA; van der Ent CK; Molin S; Yang L; Hansen SK; Rau MH; Ciofu O; Johansen HK; Wolfs TF
Clin Microbiol Infect; 2012 Jun; 18(6):567-74. PubMed ID: 21883670
[TBL] [Abstract][Full Text] [Related]
20. Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients.
King P; Citron DM; Griffith DC; Lomovskaya O; Dudley MN
Diagn Microbiol Infect Dis; 2010 Feb; 66(2):181-6. PubMed ID: 19828274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]